BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 7
• 8
• 9
• 10
• 13
• 14
• 15
• 16
• 17
• 20
• 21
• 22
• 23
• 24
• 27
• 28
• 29
• 30

• Drug Development

  Cyclacel Pharmaceuticals, Inc. Reaches Agreement With FDA on a Special Protocol Assessment for Pivotal Phase 3 Trial of Sapacitabine in AML

  September 13, 2010

   · 

  7 min read
• Business

  Pharming Group Signs Commercialization Agreement With Santarus Inc. For Rhucin(R) In North America; Santarus to Pay $15 Million Upfront

  September 13, 2010

   · 

  5 min read
• Pharm Country

  Amorcyte Inc. Granted Landmark Patent

  September 13, 2010

   · 

  3 min read
• Octapharma AG’s Drive to Prevent and Eradicate FVIII Antibody Inhibitors in Haemophilia Treatment

  September 13, 2010

   · 

  1 min read
• Drug Development

  TetraPhase Pharmaceuticals Presents New Clinical and Preclinical Data for Novel AntibioticTP-434 at 2010 ICAAC

  September 13, 2010

   · 

  1 min read
• BioMidwest

  Otix Global, Inc. to Discontinue German Operations

  September 13, 2010

   · 

  3 min read
• BioCapital

  Intas Biopharmaceuticals Ltd. Enters Medical Devices Market Through Deal with Insight Medical Inc.

  September 13, 2010

   · 

  1 min read
• Drug Development

  Trevena, Inc. Presents Preclinical Data for TRV120027, a Biased AT1R Ligand, at the 14th Annual Heart Failure Society of America Meeting

  September 13, 2010

   · 

  1 min read
• Drug Development

  XenoPort, Inc. Announces Plans for Phase 3 Development of Arbaclofen Placarbil for Spasticity

  September 13, 2010

   · 

  1 min read
• Aspirin Reduces Cardiac Events, Mortality in Kidney Patients

  September 13, 2010

   · 

  1 min read